Narcolepsy
103
14
14
71
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
26 trials with published results (25%)
Research Maturity
71 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.9%
3 terminated out of 103 trials
95.9%
+9.4% vs benchmark
25%
26 trials in Phase 3/4
37%
26 of 71 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 71 completed trials
Clinical Trials (103)
Decreasing Nightmares in Adults With Narcolepsy
Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence
A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Narcolepsy Nightmare Study
A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)
WAKIX® (Pitolisant) Pregnancy Registry
Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Test
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia
A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy
Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)
Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy
Observational Study of LUMRYZ in Narcolepsy
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research